Monthly 2-Shot Combo a Promising Alternative

The FDA’s approval of the first long-acting HIV drug combination yesterday promises to boost the quality of life for people under treatment—trading 3 daily pills for a monthly round of 2 injections, the AP reports.
The new treatment, called Cabenuva, could help reduce stigma, make it easier to keep treatment on track, and improve access for hard-to-reach groups. 
That’s key especially for people with spotty access to health care or those with mental health issues or substance use problems.
The daily pills are a struggle for many, the New York Times notes, and the consequences can be steep—as missed meds can help the virus develop resistance.
One Caveat: The clinical trials only included people who have already gotten the disease under control with conventional meds.

Secondary Topic
Comments +


Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top